Daily aspirin use is associated with a reduced risk of ER-positive breast cancer

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Oncology | 2008年 / 5卷 / 8期
关键词：
D O I：
10.1038/ncponc1165
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：432 / 432
相关论文
共 50 条
  • [11] Predicting late recurrence in ER-positive breast cancer
    Jack Cuzick
    Nature Reviews Clinical Oncology, 2019, 16 : 406 - 408
  • [12] What is the best therapy for ER-positive breast cancer?
    不详
    EJC SUPPLEMENTS, 2004, 2 (09): : 62 - 64
  • [13] Predicting late recurrence in ER-positive breast cancer
    Cuzick, Jack
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) : 406 - 408
  • [14] The role of the AR/ER ratio in ER-positive breast cancer patients
    Rangel, Nelson
    Rondon-Lagos, Milena
    Annaratone, Laura
    Osella-Abate, Simona
    Metovic, Jasna
    Mano, Maria Piera
    Bertero, Luca
    Cassoni, Paola
    Sapino, Anna
    Castellano, Isabella
    ENDOCRINE-RELATED CANCER, 2018, 25 (03) : 163 - 172
  • [15] Statin and aspirin use is not associated with a reduced risk of VTE's in breast cancer patients
    Shai, A.
    Rennert, H. S.
    BaIlan, Haj M.
    Lavie
    Steiner, M.
    Rennert, G.
    CANCER RESEARCH, 2012, 72
  • [16] Frequency and Significance of Basal Phenotype in ER-positive Breast Cancer
    Meyer, Anne-Sophie
    Kriegsmann, Mark
    Waldburger, Nina
    Jung, Audrey
    Behrens, Sabine
    Chang-Claude, Jenny
    Sinn, Hans-Peter
    MODERN PATHOLOGY, 2018, 31 : 91 - 91
  • [17] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Alomran, Reem
    White, Michelle
    Bruce, Melissa
    Bressel, Mathias
    Roache, Susan
    Karroum, Lama
    Hanna, Gerard G.
    Siva, Shankar
    Goel, Shom
    David, Steven
    BMC CANCER, 2021, 21 (01)
  • [18] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [19] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    Breast Cancer Research, 7
  • [20] The prognostic effects of somatic mutations in ER-positive breast cancer
    Griffith, Obi L.
    Spies, Nicholas C.
    Anurag, Meenakshi
    Griffith, Malachi
    Luo, Jingqin
    Tu, Dongsheng
    Yeo, Belinda
    Kunisaki, Jason
    Miller, Christopher A.
    Krysiak, Kilannin
    Hundal, Jasreet
    Ainscough, Benjamin J.
    Skidmore, Zachary L.
    Campbell, Katie
    Kumar, Runjun
    Fronick, Catrina
    Cook, Lisa
    Snider, Jacqueline E.
    Davies, Sherri
    Kavuri, Shyam M.
    Chang, Eric C.
    Magrini, Vincent
    Larson, David E.
    Fulton, Robert S.
    Liu, Shuzhen
    Leung, Samuel
    Voduc, David
    Bose, Ron
    Dowsett, Mitch
    Wilson, Richard K.
    Nielsen, Torsten O.
    Mardis, Elaine R.
    Ellis, Matthew J.
    NATURE COMMUNICATIONS, 2018, 9
12345